Cas no 36082-50-5 (5-Bromo-2,4-dichloropyrimidine)
5-Bromo-2,4-dichloropyrimidine Chemical and Physical Properties
Names and Identifiers
-
- 5-bromo-2,4-dichloropyrimidine
- BUTTPARK 48\06-22
- 2,4-DICHLORO-5-BROMO PYRIMIDINE
- TIMTEC-BB SBB003301
- 5-Bromo-2,4-Dichloropyridimidine
- 2,4-Dichloro-5-bromopyrimidine See B684030
- 2,4-Dichloro-5-bromopyrimidineSee B684030
- 5-Bromo-2,4-dichloropyrimidine See D433775
- 2,4,4-TRIMETHYLCYCLOPENTANONE
- 5-Brom-2,4-dichlor-pyrimidin
- 5-bromo-2,4-dichloropyrimdine
- 5-Bromo-2,4-dichloro-pyrimidine
- 5-Bromo-2,4-dichloror-pyrimidine
- 2,4-dichloro-5-bromopyrimidine
- PYRIMIDINE, 5-BROMO-2,4-DICHLORO-
- SIKXIUWKPGWBBF-UHFFFAOYSA-N
- 2,4-Dichloro-5-bormopyrimidine
- NSC152517
- zlchem 380
- PubChem3993
- KSC226I5J
- 5-bromo-2,4dichloropyrimidine
- 5-bromo-2,4-dichlorpyrimidine
- 5-bromo-2,4dichloro-pyrimidine
- 2,6-dichloro-5-bromopyrimidine
- SIKXIUWKP
- W-202499
- AB03550
- F2108-0250
- Palbociclib impurity 99
- DTXSID40302656
- FT-0700569
- 5-Bromo-2,4-dichloropyrimidine, 97%
- 5-bromanyl-2,4-bis(chloranyl)pyrimidine
- InChI=1/C4HBrCl2N2/c5-2-1-8-4(7)9-3(2)6/h1H
- MFCD00127818
- FT-0620073
- BCP22990
- SIKXIUWKPGWBBF-UHFFFAOYSA-
- PS-6296
- AKOS002663027
- 5-bromo-2, 4-dichloropyrimidine
- EN300-71646
- NSC 152517
- CS-D1117
- Z1142701237
- SCHEMBL217854
- AM20090573
- A823117
- A6265
- 36082-50-5
- NSC-152517
- B2823
- AF-399/25108039
- AC-3063
- Discontinued, see D433775
- 5-Bromo-2,4-Dichloropyrimidine,98%
- DB-013968
- DTXCID40253790
- DB-317259
- 5-Bromo-2,4-dichloropyrimidine
-
- MDL: MFCD00127818
- Inchi: 1S/C4HBrCl2N2/c5-2-1-8-4(7)9-3(2)6/h1H
- InChI Key: SIKXIUWKPGWBBF-UHFFFAOYSA-N
- SMILES: BrC1=CN=C(N=C1Cl)Cl
- BRN: 124441
Computed Properties
- Exact Mass: 225.87000
- Monoisotopic Mass: 225.87
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 9
- Rotatable Bond Count: 0
- Complexity: 103
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 25.8
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 2.8
Experimental Properties
- Color/Form: solid
- Density: 1.781?g/mL?at 25?°C(lit.)
- Melting Point: 29-30?°C (lit.)
- Boiling Point: 128?°C/15?mmHg(lit.)
- Flash Point: Degrees Fahrenheit:235.4°F
Degrees Celsius:113°C - Refractive Index: n20/D 1.603(lit.)
- PSA: 25.78000
- LogP: 2.54590
- Solubility: Insoluble
5-Bromo-2,4-dichloropyrimidine Security Information
-
Symbol:
- Prompt:dangerous
- Signal Word:Danger
- Hazard Statement: H301+H311+H331,H314
- Warning Statement: P261,P280,P301+P310,P305+P351+P338,P310
- Hazardous Material transportation number:UN 3263 8/PG 2
- WGK Germany:3
- Hazard Category Code: 23/24/25-34-43
- Safety Instruction: S26-S27-S36/37/39-S45
-
Hazardous Material Identification:
- Packing Group:III
- Hazard Level:8
- Risk Phrases:R23/24/25; R34
- Packing Group:III
- Safety Term:8
- HazardClass:8 (6.1)
- PackingGroup:II
- Storage Condition:Store long-term at 2-8°C
5-Bromo-2,4-dichloropyrimidine Customs Data
- HS CODE:2933599090
- Customs Data:
China Customs Code:
2933599090Overview:
2933599090. Other compounds with pyrimidine ring in structure(Including other compounds with piperazine ring on the structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Bromo-2,4-dichloropyrimidine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B803838-500g |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 98% | 500g |
958.00 | 2021-05-17 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 416762-5G |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 5g |
¥915.2 | 2023-12-06 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 416762-25G |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 25g |
¥1236.74 | 2023-12-06 | ||
| Matrix Scientific | 001239-25g |
5-Bromo-2,4-dichloropyrimidine, 98% |
36082-50-5 | 98% | 25g |
$37.00 | 2023-09-06 | |
| Matrix Scientific | 001239-100g |
5-Bromo-2,4-dichloropyrimidine, 98% |
36082-50-5 | 98% | 100g |
$113.00 | 2023-09-06 | |
| ChemScence | CS-D1117-500g |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 99.79% | 500g |
$98.0 | 2022-04-27 | |
| ChemScence | CS-D1117-1000g |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 99.62% | 1000g |
$220.0 | 2021-09-02 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R001571-1g |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 98% | 1g |
¥25 | 2024-05-24 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R001571-25g |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 98% | 25g |
¥43 | 2024-05-24 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R001571-5g |
5-Bromo-2,4-dichloropyrimidine |
36082-50-5 | 98% | 5g |
¥35 | 2024-05-24 |
5-Bromo-2,4-dichloropyrimidine Suppliers
5-Bromo-2,4-dichloropyrimidine Related Literature
-
Yu Fang,Dawei Wang,Xingyu Xu,Gila Dava,Jianping Liu,Xiang Li,Qianqian Xue,Huan Wang,Jiangshan Zhang,Huabei Zhang RSC Adv. 2018 8 10333
-
Colin B. Reese,Qinpei Wu Org. Biomol. Chem. 2003 1 3160
-
3. A synthesis of pseudouridine and of 5-β-D-ribofuranosyluridineD. M. Brown,M. G. Burdon,R. P. Slatcher J. Chem. Soc. C 1968 1051
-
Dawei Wang,Yu Fang,Hang Wang,Xingyu Xu,Jianping Liu,Huabei Zhang RSC Adv. 2017 7 22388
-
5. 623. Pyrimidines. Part VI. 5-BromopyrimidineJ. F. W. McOmie,I. M. White J. Chem. Soc. 1953 3129
Additional information on 5-Bromo-2,4-dichloropyrimidine
Introduction to 5-Bromo-2,4-dichloropyrimidine (CAS No. 36082-50-5)
5-Bromo-2,4-dichloropyrimidine, with the chemical formula C?H?BrCl?N? and CAS number 36082-50-5, is a significant intermediate in the field of organic synthesis and pharmaceutical chemistry. This compound belongs to the pyrimidine class of heterocyclic aromatic compounds, which are widely recognized for their diverse biological activities and utility in drug development. The presence of both bromine and chlorine substituents on the pyrimidine ring enhances its reactivity, making it a valuable precursor for synthesizing more complex molecules.
The structural features of 5-Bromo-2,4-dichloropyrimidine contribute to its versatility in chemical transformations. The bromine atom at the 5-position and the chlorine atoms at the 2- and 4-positions provide multiple sites for nucleophilic substitution reactions, allowing for the introduction of various functional groups. This property is particularly useful in medicinal chemistry, where modifications at specific positions on a molecular scaffold can significantly alter biological activity.
In recent years, 5-Bromo-2,4-dichloropyrimidine has garnered attention in the development of novel therapeutic agents. Its role as a building block in constructing pharmacophores has been explored in several research areas, including antiviral, anticancer, and anti-inflammatory drug discovery. The compound’s ability to undergo cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, makes it an attractive candidate for generating biaryl structures, which are prevalent in many active pharmaceutical ingredients (APIs).
One of the most compelling applications of 5-Bromo-2,4-dichloropyrimidine is in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with diseases such as cancer. By incorporating 5-Bromo-2,4-dichloropyrimidine into kinase inhibitor molecules, researchers can design compounds that selectively target specific kinases, thereby modulating signaling pathways involved in disease progression. For instance, derivatives of this compound have been investigated as potential inhibitors of tyrosine kinases, which are key players in tumor growth and metastasis.
The pharmaceutical industry has also leveraged 5-Bromo-2,4-dichloropyrimidine in the development of antiviral drugs. Pyrimidine-based molecules are known for their ability to mimic natural nucleobases, making them effective against viruses that rely on nucleic acid replication. Researchers have synthesized analogs of 5-Bromo-2,4-dichloropyrimidine that exhibit inhibitory activity against viral polymerases by competing with natural substrates or by inducing structural changes in viral enzymes. These studies highlight the compound’s potential as a scaffold for antiviral therapies.
Furthermore, 5-Bromo-2,4-dichloropyrimidine has found utility in materials science and agrochemical research. Its reactivity allows for the construction of complex organic frameworks that can be used in advanced materials with applications ranging from electronics to catalysis. In agrochemistry, derivatives of this compound have been explored as herbicides and fungicides due to their ability to interfere with essential metabolic pathways in plants and fungi.
The synthesis of 5-Bromo-2,4-dichloropyrimidine typically involves chlorination and bromination reactions starting from simpler pyrimidine precursors. Advanced synthetic methodologies have been developed to improve yield and purity while minimizing side reactions. Techniques such as palladium-catalyzed cross-coupling reactions have been optimized for introducing functional groups at specific positions on the pyrimidine ring with high precision.
Recent advances in computational chemistry have further enhanced the understanding of 5-Bromo-2,4-dichloropyrimidine’s reactivity and its role in drug design. Molecular modeling studies have provided insights into how structural modifications influence biological activity, enabling researchers to predict the properties of novel derivatives before experimental synthesis. This integration of computational methods with traditional synthetic approaches has accelerated the discovery process in medicinal chemistry.
The safety profile of 5-Bromo-2,4-dichloropyrimidine is another critical consideration in its application. While it is not classified as a hazardous material under standard regulatory guidelines, proper handling procedures must be followed to ensure worker safety during synthesis and handling. Storage conditions should be controlled to prevent degradation or unwanted side reactions.
In conclusion,5-Bromo-2,4-dichloropyrimidine (CAS No. 36082-50-5) is a versatile intermediate with broad applications across multiple scientific disciplines. Its role in pharmaceutical development continues to evolve with advancements in synthetic chemistry and computational methods. As research progresses,5-Bromo-2,4-dichloropyrimidine will likely remain a cornerstone compound for designing novel therapeutic agents and functional materials.
36082-50-5 (5-Bromo-2,4-dichloropyrimidine) Related Products
- 68791-17-3(5-Bromo-4,6-dichloropyrimidine)
- 1220039-87-1(5-Bromo-4-chloro-pyrimidine hydrochloride)
- 68797-61-5(5-Bromo-4,6-dichloropyrimidine)
- 56181-39-6(5-Bromo-4-chloropyrimidine)
- 1643562-80-4(5-Bromo-4-chloro-2-(methyl-d3)-pyrimidine)
- 2826916-60-1(5-bromo-4-chloro-2-(methyl-d3)pyrimidine-6-d)
- 63931-21-5(5-Bromo-2,4,6-trichloropyrimidine)
- 861383-73-5(5-Bromo-4-chloro-2-methylpyrimidine)
- 2363787-76-0(5-bromo-4-chloropyrimidine-2,6-d2)
- 2167898-16-8(5-bromo-2,4-dichloropyrimidine-6-d)